Pfizer increases Irish workforce by 10 percent with 500 new jobs in a €1.2 billion investment

Pfizer will create up to 500 new jobs by investing more than €1.2 billion in its Grange Castle manufacturing facility in Dublin.

The pharma giant said it was its biggest expansion in Ireland to date, with a new facility being built on the site that will double capacity for manufacturing biologics there.

Pfizer said this would mean adding 400 to 500 new jobs, bringing the total number employed here to 5,500.

“The investment and roles created will significantly expand manufacturing and laboratory capabilities and add new technologies to ensure Pfizer is ready to support the next wave of medical innovation,” the company said.

The project is in the preliminary design phase, with construction scheduled to begin in 2024 and the new facility scheduled to open in 2027, Pfizer added.

The facility will manufacture products in the areas of oncology, rare diseases, inflammation and immunology, and internal medicine.

This was followed by a €40 million investment in the site last year when Grange Castle was added to Pfizer’s Covid-19 global manufacturing network. Grange Castle, along with Pfizer’s other sites in Newbridge, Co. Kildare and Ringaskiddy, Co. Cork, manufacture medicines and vaccines for arthritis, inflammation, cancer, anti-infectives, hemophilia, pain and stroke.

A Taoiseach Micheál Martin welcomed the announcement.

“This is a truly significant investment and appointment by Pfizer – its largest expansion in Ireland to date – and a significant vote of confidence in the talent of our workforce and our economy. Pfizer has played a critical role during the pandemic,” he said.

“It is gratifying to see the amount of scientific advances that have been made in recent years and I have no doubt that Ireland will continue to be at the forefront of scientific innovation. I wish the entire Pfizer team here in Ireland continued success as they work towards improving the lives of patients in Ireland and beyond.”

Mike McDermott, Chief Global Supply Officer, Executive Vice President, Pfizer, said: “We are very pleased with today’s announcement as it significantly strengthens our operations in Ireland where we have three strong and strategic manufacturing facilities.

“Grange Castle has played a critical role in our global Covid-19 vaccine network and this investment in non-Covid licensed and pipelined products will help further expand the site’s broad and robust capabilities.

“As this investment demonstrates, we continue to invest in our global manufacturing infrastructure to bring much-needed medicines and vaccines to patients around the world and to drive the next scientific breakthroughs.” Pfizer increases Irish workforce by 10 percent with 500 new jobs in a €1.2 billion investment

Fry Electronics Team

Fry is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – The content will be deleted within 24 hours.

Related Articles

Back to top button